President of Slovak republic, Ivan Gašparovič, has signed the amendment to the act on pharmaceuticals, which tightens the supervision over human pharmaceuticals. Amendment to the act approved in July by members of Parliament also implements the changes by the market supervision and penalties by failing to comply with the provisions of the act. It also tightens the requirements for all subjects treating with human pharmaceuticals, especially the holders of human pharmaceutical registration.